THE UNITED STATES PHARMACOPEIAL CONVENTION

Lobbying for THE UNITED STATES PHARMACOPEIAL CONVENTION

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · Senate · $70,000.00 expenses · posted Apr 21, 2025

Lobbying activity 1

Health Issues

Issues regarding drug shortages and pharmaceutical supply chain resilience.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.